Company Filing History:
2 out of 1,036 
1 out of 1 
2 out of 832,891 Years Active: 2002-2006
Title: The Innovations of Marc E. Lanser
Introduction
Marc E. Lanser is a notable inventor based in Dover, MA (US). He has made significant contributions to the field of medical science, particularly in the area of angiogenesis. With a total of 4 patents to his name, Lanser's work has the potential to impact the treatment of various diseases.
Latest Patents
Among his latest patents, one focuses on methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I. This invention relates to methods of inhibiting angiogenesis associated with a disease or disorder using peptides homologous to specific amino acid residues of human troponin subunit I. Another significant patent involves pharmaceutical compositions comprising recombinant troponin subunits. This invention pertains to pharmaceutical compositions that include therapeutically effective amounts of recombinant troponin C, I, or T subunits for treating diseases or disorders involving abnormal angiogenesis.
Career Highlights
Throughout his career, Marc E. Lanser has worked with various organizations, including the Children's Medical Center Corporation. His innovative approaches and research have contributed to advancements in medical treatments.
Collaborations
Lanser has collaborated with notable individuals in his field, including Richard M. Thorn and Marsha A. Moses. These collaborations have likely enriched his research and development efforts.
Conclusion
Marc E. Lanser's contributions to the field of medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of diseases related to angiogenesis.